振东制药(300158.SZ)：第三季度净利润同比上升31.34%

Core Viewpoint - Zhen Dong Pharmaceutical (300158.SZ) reported a slight decline in revenue for Q3 2025, while net profit showed significant growth, indicating a mixed performance in financial results [1] Financial Performance - The company's operating revenue for Q3 2025 was 758 million yuan, representing a year-on-year decrease of 0.69% [1] - The net profit attributable to shareholders of the listed company was 12.43 million yuan, reflecting a year-on-year increase of 31.34% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 8.68 million yuan, which marked a substantial year-on-year increase of 2253.78% [1]